(firstQuint)"Treatment of Active HBV With T Cells" Clinical Trial Protocol.

 In this clinical trial, we will thoroughly evaluate the safety of in vitro expanded T cells, including allogeneic originated T cells, in clinical treatment of active HBV.

 At the same time, we will carefully and thoroughly examine and evaluate the clinical efficacy of T cells against active HBV, including lowering speed of DNA copy number, and the transferring rate of HBeAg from positive to negative.

.

 "Treatment of Active HBV With T Cells" Clinical Trial Protocol@highlight

To evaluate the safety and anti-HBV efficacy of T cells.

